Nicole Gallo

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS1
- SINCE2008

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
April 2008 - January 2011
Lymphoma
Lymphoma, Non-Hodgkin
Hodgkin Disease
Hcd122



